Table 2.
Population | Age group | Seroprevalence | Expected width of the 95% confidence interval |
---|---|---|---|
years | % | % | |
General population | Total | 3 5 10 15 |
2.2–4.0 4.0–6.3 8.5–11.7 13.2–17.0 |
Population by age group (expected seroprevalence: 3%) |
18–34 35–49 50–64 ≥65 |
3.7 4.0 4.1 2.3 |
2.2–6.3 2.4–6.6 2.5–6.9 1.1–4.8 |
Population by age group (expected seroprevalence: 5%) |
18–34 35–49 50–64 ≥65 |
6.2 6.7 6.9 3.8 |
4.1–9.2 4.5–9.8 4.6–10.2 2.2–6.8 |
Population by age group (expected seroprevalence: 10%) |
18-34 35-49 50-64 ≥65 |
12.4 13.4 13.8 7.7 |
9.4–16.3 10.2–17.3 10.5–18.0 5.1–11.4 |
Population by age group (expected seroprevalence: 15%) |
18-34 35-49 50-64 ≥65 |
18.6 20.1 20.7 11.5 |
14.9–23.0 16.2–24.5 16.7–25.4 8.3–15.8 |